TNF Inhibitor denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for tnf inhibitor are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Applies Step Therapy to TNF Inhibitors

UHC uses step therapy (sometimes called "fail-first" requirements) for TNF inhibitors, requiring that patients try one or more lower-cost conventional disease-modifying agents or other specified therapies before the insurer will cover a biologic. A step-therapy denial means UHC's records do not reflect completed steps — either because the prior therapies were not documented in the claim, were not tried for the required duration, or were not the specific agents listed in UHC's current step protocol.

Step therapy is one of the most appealed denial types, and it has the highest reversal rate when prior treatment history is well-documented.

## Why This Denial Is Appealable

Step-therapy denials are directly appealable when (a) you have already tried and failed or are contraindicated to the required step agents, (b) your prescriber has a clinical reason why skipping a step is medically necessary, or (c) you were already stable on the TNF inhibitor before switching plans (continuity-of-care protections apply in many states and under certain federal rules). Under ACA §2719 and ERISA §503, you have internal-appeal and independent external-review rights. Many states also have step-therapy override statutes that create additional rights.

## Federal Appeal Framework

• Internal appeal: File within 180 days of the denial with a full clinical package addressing each step requirement.
• State step-therapy override law: Check whether your state has enacted a step-therapy override statute (many have since 2018); these typically allow an override when prior-step agents failed, caused adverse effects, or are contraindicated.
• External review: Available after internal exhaustion; the IRO must independently evaluate whether step-therapy application was appropriate.
• Expedited option: Available when the standard timeline would seriously harm your health.

## Documentation to Gather

1. Complete prior-treatment timeline — pharmacy records, insurance EOBs, and prescriber notes for every step agent UHC requires, showing drug name, start date, end date, dose adjustments, and documented reason for discontinuation (failure, intolerance, or contraindication). 2. Step-protocol identification — obtain UHC's current published step-therapy protocol for TNF inhibitors for your specific indication so you can demonstrate compliance with each step. 3. Contraindication or intolerance records — if a required step agent could not be used, chart documentation of the specific clinical reason (lab findings, adverse event note, specialist assessment). 4. Prescriber step-therapy exception letter — a letter from the treating physician stating which steps were completed, why remaining steps are not appropriate, and why the TNF inhibitor is now medically necessary. 5. Continuity-of-care documentation — if you were already on the TNF inhibitor under a prior plan, prior authorization approval letters, pharmacy records, and a prescriber stability note. 6. Applicable specialty guideline reference — citation to the relevant guideline organization (e.g., ACR, ACG, AAD) endorsing TNF inhibitor use after the completed steps.

## Criteria-Mapping Structure

Map each step in UHC's protocol against the clinical record:

| Step Requirement (from UHC policy) | Chart Evidence | |---|---| | Step 1 agent tried for required duration | Pharmacy record dates ___ / outcome ___ | | Step 2 agent tried or contraindicated | Chart note / adverse event record, date ___ | | Additional steps completed or excepted | Records as above | | Prescriber specialty confirmation | Treating physician credentials |

Verify the exact agents and durations required by reviewing UHC's current published step-therapy policy and the FDA-approved prescribing information for the TNF inhibitor — these are the authoritative sources for the specific criteria that must be addressed in your appeal.